Therefore, the aim of this review was to discuss a large body of evidence on the therapeutic potential of human IGF-1 in diabetes complications and to understand the mechanism and metabolic links of IGF in diabetes complications. The gene discussed is IGF1; the disease is diabetes mellitus.